Ciencia e Ingeniería en Alimentos y Biotecnología
URI permanente para esta comunidadhttp://repositorio.uta.edu.ec/handle/123456789/412
Examinar
9 resultados
Resultados de la búsqueda
Item type:Ítem, Descripción general de las metodologías de detección y cuantificación de SARS-CoV-2 en muestras clínicas(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2022-09) ;Sailema Ronquillo, Wendy AbigailCalero Cáceres, William RicardoAt the end of 2019, a new type of coronavirus appeared, known as SARS-CoV-2, which causes the disease COVID-19. This virus spread rapidly and in March 2020 it was declared a pandemic by COVID-19. The most common symptoms of the disease are fever, muscle pain, shortness of breath, cough, loss of smell and taste, headache and diarrhea in 10 percent of infected patients. On the other hand, there are patients who do not present any symptoms, known as asymptomatic patients. Among the critical factors for an adequate response to a viral pandemic, timely detection and isolation of potentially infected individuals are considered first. Thus, the appearance of new variants (alpha, delta, omicron) and the study of the complete genome sequencing of SARS-CoV-2 allowed the development of new molecular analysis technologies. The main objective of this research was to investigate the methodologies for the detection and quantification of SARS-CoV-2. For the development of the study, inclusion and exclusion criteria were proposed, such as: books, articles, documents and reports of scientific bases and research carried out at from the year 2019. As a result, approximately 150 documents were obtained that were analyzed for the present investigation. Specifically, the different technologies available, the types of samples and their processing, SARS-CoV-2 whole genome sequencing techniques, as well as the advantages and limitations of current methods were studied.Item type:Ítem, Estudios bioinformáticos sobre la proteína Spike del SARS CoV-2 para el desarrollo de posibles inhibidores(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-03) ;Villacis Perez, Nestor AlexanderTerán Mera, David AndrésWith the worldwide alarm of COVID-19 multiple laboratories were dedicated to the search for a vaccine, for these studies it is imperative to work in a laboratory, however, there are ways in which you can contribute to the development of treatments against this disease, one way that is addressed in this project is an in silico analysis, which by molecular docking. Molecular docking was performed with the SARS-CoV-2 Spike protein as a receptor and 13,602 compounds from the CASPeR, ChemBridge and Pathogen Box libraries as ligands. The docking yielded binding affinity (BA) data, results that helped to choose the ligands whose BA was between -6.8 and -5.8 kcal/mol, however, since it was too large a number it was reduced to the 11 best ligands, these were analyzed graphically, so that the distance, number and type of non-covalent interactions were collected. In addition to the BA, the dissociation constant (Kd) was also calculated, which verified that the chosen ligands were able to form interactions that can be taken into account for the development of inhibitors, however, the Kd found are not comparable with the Kd of 14.7 nM that exists between the hACE2 receptor and spike of SARS-CoV-2. Graphical analysis of the 11 ligands revealed that they were able to form highly valuable interactions such as hydrogen bridges, aromatic, hydrophobic and halogen interactions. Interactions with the potential to block the interactions between hACE2 and Spike of SARS-CoV-2, leaving grounds for further studies.Item type:Ítem, Análisis comparativo de las proteínas espiga de los coronavirus: MERS CoV, SARS CoV y SARS CoV-2 y sus respectivos receptores(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-03) ;Nauque Villacís, Jason DamianTerán Mera, David AndrésAt the end of 2019, the discovery of a new coronavirus with the capacity to infect humanswas reported. This coronavirus causes Severe Acute Respiratory Syndrome 2 (SARSCoV- 2). Being the seventh virus of this family that has entered the human being, concern arises about the capacities that these viruses have to adapt to new hosts. This is how the spike proteins of hCoVs were analyzed, with a main emphasis on those with pathogenic and virulent capacities, without neglecting hCoVs. The spike protein is responsible for receptor recognition, as well as being part of the genome that mutates the most in all CoVs. For this reason, the conserved sites of those hCoVs were analyzed. In the present work, the conserved sites of the receptor binding domains (RBD) were analyzed. A phylogenetic analysis was carried out to determine the proximity with other CoVs of animal origin and hypothesize the CoVs with zoonotic capacity.Item type:Ítem, Identificación y modelamiento de mutaciones que otorgan resistencia a inhibidores de la enzima proteasa Mpro del virus SARS-CoV2(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01) ;Vizueta Rubio, Carolina BelénGarcía Solís, Mario DanielIn January 2020, an outbreak of a new Coronavirus (CoV-2) was reported, which causes Acute Respiratory Syndrome (SARS). SARS-CoV-2 now does not have therapeutic options that prevent or stop the viral infection. One of the targets for developing drugs against this virus is its main protease, Mpro. The compounds Carmofur and N3 have been shown to exhibit potent Mpro inhibitory activity. However, the SARS-CoV-2 genome mutates rapidly. The present work proposes the modeling of the structures of point mutations in the main protease of SARS-COV-2 and the analysis of the implications that these would have on the interaction with Carmofur and N3. A multiple alignment of the viral proteins homologous to Mpro suggests that the structure of the Mpro protease of SARS-CoV-2 could undergo modifications in the amino acids of the active site. The possible mutations identified were modeled in Wincoot and refined in YASARA. The analysis of possible variations in the binding properties of Carmofur and N3 to Mpro was carried out by molecular coupling. The results show that point mutations in the active site of Mpro can modify the mode of binding of these inhibitors to the enzyme, giving rise to the appearance of resistance. These results are of great relevance, since they allow us to anticipate the effect of different mutations in the way in which potential Mpro inhibitors act and thus design new inhibitors that can overcome the effect of resistance to these drugs.Item type:Ítem, Cribado virtual de inhibidores de la enzima Mpro del virus SARS-CoV-2 empleando librerías de compuestos y homología estructural con proteasas de virus patógenos humanos(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01) ;Sánchez Vaca, Andrés SalomónGarcía Solís, Mario DanielThe present research project was carried out to find and develop ligands with inhibitory activity against the Mpro protease of the SARS CoV-2 virus through a virtual screening of recently developed inhibitors against this and those that have been previously tested in human pathogenic viruses. For which, compound libraries such as Protein Data Bank were used, from which 46 molecules with a high binding affinity to Mpro were chosen from a study of structural homology with the proteases of other viruses that attack humans and Covid Box. library that can be accessed from the following domain: https://www.mmv.org/mmv-open/covid-box from where a total of 79 molecules were taken, the selected ligands were presented as inhibitors of Mpro, at starting from the formation of hydrophobic, polar interactions and pi bonds between carbon - carbon, sulfur - carbon and fluorine - carbon atoms. To select the best molecules, a bioinformatic analysis was carried out in software such as Wincoot, Pymol and GOLD - Protein Ligand Docking Software, the latter for docking or molecular docking tests, studied at a conformational level by the arrangement and overlapping of atoms, level of incidence of intermolecular interactions and the possibility of steric shocks of their functional groups, obtaining as a result that the MMV1580167 molecule from Covid Box presents the best inhibitory activity within the virtual screening, while the designed AS7 ligand presents the highest inhibitory activity in the virtual environment where the investigation was carried out.Item type:Ítem, Cribado virtual de inhibidores de la enzima Mpro del virus SARS-CoV-2 empleando librerías de compuestos y homología estructural con proteasas de virus patógenos de animales(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01) ;Ramos Aristimbay, María LisetteGarcía Solís, Mario DanielThe purpose of this study is to perform virtual screening of SARS-CoV-2 virus Mpro enzyme inhibitors using compound libraries and structural homology with animal pathogenic virus proteases. In response to the present pandemic the world is going through, caused by COVID-19, so it is of paramount importance to search for compounds, which prevent the spread of SARS-CoV-2, with which medicines can be made to curb the contagions of this disease. Since the main protease Mpro is responsible for carrying out the proteolytic processes during the replication of the virus, it has been selected as a target for the search for molecules that inhibit its activity, thus preventing the virus from continuing to multiply. For this, a homology analysis was performed that could identify that this protease is preserved in several species of coronavirus that infect animals, such as those that cause murine hepatitis, swine transmissible gastroenteritis, feline peritonitis, and avian infectious bronchitis. Which allowed us to look for compounds used to treat these diseases, and to create a library with the most effective ligands. This was able to determine the druggable sites of the enzyme and perform a molecular coupling (docking), identifying ten inhibitors that best bind to Mpro, including Ritonavir, with which, through subsequent in vitro studies, COVID-19 drugs could be generated, and tested in other coronaviruses with which homology exists.Item type:Ítem, Identificación y modelamiento de mutaciones que otorgan resistencia a inhibidores de la enzima ARN polimerasa ARN dependiente del virus SARS-CoV-2(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01) ;Jaramillo Guapisaca, Karen AndreaGarcía Solís, Mario DanielThe emergence of a new severe acute respiratory syndrome coronavirus (SARS-CoV-2), of which there is not yet effective treatment, so the SARS-CoV-2 dependent RNA polymerase (RdRp) enzyme, is one of the main goals for developing compounds with antiviral activity. Based on this principle, structural analogues of nucleosides such as Favipiravir, Ribavirin and Remdesivir, particularly, the latter is an effective SARS-CoV-2 RdRp inhibitor and other RNA viruses such as MERS being a major candidate as a therapeutic option for the treatment of COVID-19. Key RdRp residues of the virus, which assist in the junction of Remdesivir that maintain non-covalent interactions, were identified. The degree of conservation of these residues was analyzed by multiple sequence alignment with RdRps. This analysis allowed mutant variants to be modeled in three specific positions of the enzyme's active site, Val557Ile, Ala688Gly and Ser759Thr, and evaluate the effect of these mutations on the binding properties of the inhibitor. Affinity and free energy were determined by molecular coupling in the GOLD program. The results show that all three mutations decrease Remdesivir's theoretical affinity for the active RdRp site. The most harmful mutation for the binding of Remdesivir with the enzyme was the Val557Ile variant with an affinity Score 1.4 times lower than that observed for the native enzyme. These results allow us to foresee the effect of possible changes that may occur in the viral polymerase in a natural way and to generate therapeutic alternatives to counteract the effect of resistance to RdRp inhibitors, such as Remdesivir.Item type:Ítem, Estudios bioinformáticos de la enzima convertidora de angiotensina en humanos (hACE2) para el desarrollo de posibles inhibidores contra el SARS-CoV-2(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01) ;Hoyos Caicedo, Jhoni JavierTerán Mera, David AndrésThe bioinformatic studies carried out on human angiotensin converting enzyme 2 (hACE2) for the development of possible inhibitors against the SARS-CoV-2 virus, were mainly joint molecular docking. Docking was mainly based on detect interactions between ligands belonging to three libraries. The libraries used were three, CASPeR, ChemBridge and Pathogen Box. From each library, a group of compounds were chosen for docking. From the CASPeR library, the compounds named Drug (3517 ligands) were chosen from the ChemBridge compound library the Fragment Library (10064 ligands) were chosen. Finally, the Pathogen Box compounds (400 ligands), belonging to Medicine for Malaria Venture. The purpose of the present study was to determine the compounds (ligands) that have the potential to be inhibitors of the hACE2 receptor. After analyzing the results by means of binding affinity and intermolecular interactions, 15 ligands with the best interaction were found in the enzyme-ligand complex. These ligands have the potential to be inhibitors of an active site zone, when docking in the amino acids Lysine-31 (Lys-31), Glutamate-35 (Glu-35), Aspartate-38 (Asp-38) and Lysine- 353 (Lys-353). The present study is important since, having carried out docking studies with different ligands, it was possible to obtain those with the best interaction. The results obtained can be used to carry out in vitro and in vivo studies with the virus.Item type:Ítem, Cribado virtual de inhibidores de la enzima ARN polimerasa ARN-dependiente (RdRp) del virus SARS-CoV-2, empleando librerías de compuestos y homología estructural con ARN polimerasas virales(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-01) ;Espín Sánchez, Daysi de LourdesGarcía Solís, Mario DanielIn late 2019, an unknown human respiratory disease, later designated as COVID-19, emerged in Wuhan-China, caused by a new coronavirus denominated SARS-CoV-2. The exploration of the SARS-CoV-2 genome and the study of its life cycle have made it possible to identify potential pharmacological targets. One of the most promising is the RNA-dependent RNA polymerase enzyme (RdRp), a key component of the viral replication/transcription mechanism. In this context, the goal of this research was to perform the virtual screening of SARS-CoV-2 RdRp inhibitors, to identify the most appropriate according to the properties of their binding affinity to the enzyme. A homology analysis using protein databases determined that 65 viral polymerases share sequence similarities, secondary structure, or both, with that of SARS-CoV-2, while their multiple sequence alignment showed that the RdRp active site is highly conserved across species. Additionally, using GOLD, molecular docking essays were performed with two target sites identified in the enzyme, one corresponding to the active site and the other to a theoretical allosteric site, in which a total of 285 compounds were tested. Thus, the results show that the compounds R7112, 23E and Lopinavir bind to the active site, while Favipiravir, Triparanol and Anagliptin bind to the allosteric site could be potential inhibitors of RdRp and therefore, candidates for the development of drugs to treat COVID-19.
